Compounds > 1,2-distearoyllecithin
Page last updated: 2024-08-24

1,2-distearoyllecithin and fluorouracil

1,2-distearoyllecithin has been researched along with fluorouracil in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chantres, JR; Elorza, B; Elorza, MA; Frutos, G1
Bally, MB; Edwards, K; Hare, JI; Kapanen, AI; Karlsson, G; Ramsay, E; Thomas, AM1
Banerjee, S; Guha, SK; Pal, TK; Sen, K1
Anantha, M; Bally, MB; Harasym, N; Manisali, I; Masin, D; Osooly, M; Ostlund, C; Santos, ND; Strutt, D; Sutherland, BW; Waterhouse, DN; Webb, MS; Wehbe, M1

Other Studies

4 other study(ies) available for 1,2-distearoyllecithin and fluorouracil

ArticleYear
Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: study of drug release.
    Biochimica et biophysica acta, 1993, Dec-12, Volume: 1153, Issue:2

    Topics: Animals; Cattle; Drug Carriers; Fluorouracil; Freezing; Kinetics; Liposomes; Phosphatidylcholines; Sphingomyelins

1993
Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
    Journal of controlled release : official journal of the Controlled Release Society, 2011, Mar-10, Volume: 150, Issue:2

    Topics: Animals; Biological Availability; Body Weight; Cell Survival; Cholesterol; DNA-Binding Proteins; Drug Delivery Systems; Drug Stability; Female; Fluorouracil; HT29 Cells; Humans; Inhibitory Concentration 50; Injections, Intraperitoneal; Liposomes; Mice; Mice, Inbred BALB C; Mice, Knockout; Microscopy, Electron, Transmission; Neoplasms; Organometallic Compounds; Particle Size; Phosphatidylcholines; Polyethyleneimine; Static Electricity; Treatment Outcome; Xenograft Model Antitumor Assays

2011
Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy.
    International journal of pharmaceutics, 2012, Oct-15, Volume: 436, Issue:1-2

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Cytosol; Erythrocytes; Fluorouracil; Hemolysis; HT29 Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Male; Maleates; Mice; NIH 3T3 Cells; Phosphatidylcholines; Polystyrenes

2012
Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities.
    Investigational new drugs, 2014, Volume: 32, Issue:6

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Cholesterol; Colon; Diarrhea; Disease Models, Animal; Drug Therapy, Combination; Female; Fluorouracil; Intestine, Small; Irinotecan; Liposomes; Nanoparticles; Phosphatidylcholines; Rats, Sprague-Dawley

2014